Familiar outbreak of sporotrichosis with atypical manifestation in Southern Brazil
One Health Mycology · 2023
DOI: 10.63049/ohm.25.22.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift One Health Mycology, 2023. Verfasst von Abraão Rosa Lima Machado und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Sporotrichosis, a mycosis of implantation caused by Sporothrix spp., is an emerging disease with a high burden in Brazil. Zoonotic transmission by S. brasiliensis species occurs mainly through cats infected with the fungus. We report an outbreak of zoonotic sporotrichosis in a family of four people living in the same house with their domestic cat. Of the four patients, three presented atypical manifestations of the disease (ocular and erythema multiforme). The diagnosis was confirmed by mycological culture, and treatment with itraconazole resulted in cure with a mean resolution time of 116 days. Our report emphasizes the importance of high clinical suspicion for sporotrichosis even in patients with atypical manifestations in hyperendemic regions in order to promote timely diagnosis and treatment for patients.
Zitieren
APA
Machado, A. R. L., Xavier, M. O., Santos, M. C. D., Blan, B. D. S., Sanchotene, K. O., Trápaga, M. R., & Poester, V. R. (2023). Familiar outbreak of sporotrichosis with atypical manifestation in Southern Brazil. One Health Mycology. https://doi.org/10.63049/ohm.25.22.6
Vancouver
Machado ARL, Xavier MO, Santos MCD, Blan BDS, Sanchotene KO, Trápaga MR, et al. Familiar outbreak of sporotrichosis with atypical manifestation in Southern Brazil. One Health Mycology. 2023. doi:10.63049/ohm.25.22.6
BibTeX
@article{Machado2023,
author = {Machado, Abraão Rosa Lima and Xavier, Melissa Orzechowski and Santos, Mônica Campos dos and Blan, Bianca dos Santos and Sanchotene, Karine Ortiz and Trápaga, Mariana Rodrigues and Poester, Vanice Rodrigues},
title = {Familiar outbreak of sporotrichosis with atypical manifestation in Southern Brazil},
journal = {One Health Mycology},
year = {2023},
doi = {10.63049/ohm.25.22.6}
}
EUVIMED